Stay updated on DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.

Latest updates to the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a newer revision of the page. This change does not modify any visible content or functionality.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. It appears to involve minor template and layout adjustments without changes to study data.SummaryDifference0.1%

- Check46 days agoChange Detected- Revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision metadata updated: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded Fallopian Tube Cancer to the Conditions section and added Genetic and Rare Diseases Information Center to the Resources.SummaryDifference0.2%

- Check89 days agoChange DetectedThe page shows a minor site maintenance update: a new Revision: v3.4.2 was added and older notices (including the funding lapse notice and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DPX-Survivac Therapy in Recurrent Ovarian Cancer Clinical Trial page.